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Hematopoietic stem cells (HSCs), which are localized in the bone marrow of adult mammals, come from hematopoietic
endothelium during embryonic stages. Although the basic processes of HSC generation and differentiation have been described
in the past, the epigenetic regulation of embryonic hematopoiesis remains to be fully described. Here, by utilizing an in vitro
differentiation system of mouse embryonic stem cells (ESCs), we identified more than 20 microRNAs that were highly enriched
in embryonic hematopoietic cells, including some (e.g. miR-10b, miR-15b, and miR-27a) with previously unknown functions
in blood formation. Luciferase and gene expression assays further revealed combinational binding and regulation of these
microRNAs by key transcription factors in blood cells. Finally, bioinformatics and functional analyses supported an interactive
regulatory control between transcription factors and microRNAs in hematopoiesis.
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INTRODUCTION
Hematopoiesis is a complex biological process in which
blood cells are continuously generated from hematopoietic
stem cells (HSCs) (Godin and Cumano, 2002). In general,
mammalian embryonic hematopoiesis occurs in two major
waves. For example, in mice, primitive blood cells emerge
in yolk sac around day 7.5 before birth, whereas definitive
HSCs appear in the region of aorta-gonad-mesonephros
1–2 days later (Bertrand et al., 2005; Cumano et al., 2000;
Dzierzak, 1999; Lensch and Daley, 2004; Long and Huang,
2015; Medvinsky and Dzierzak, 1996; Palis et al., 1999;
Zhao and Li, 2015). This dynamic developmental program
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requires exact orchestration of intrinsic and extrinsic signals
to control HSC proliferation, differentiation, and survival
(Godin and Cumano, 2002). Multiple master transcription
factors are vital determinants in this regulatory machinery
and tight coordination is needed (Elefanty et al., 1997;
Mankertz et al., 2004; Morrison et al., 1995; Schmitt et
al., 1991). Although genome-wide ChIP-Seq analyses im-
plicated a combinational interaction between a heptad of
transcription factors including SCL, LYL1, LMO2, GATA2,
RUNX1, ERG, and FLI1 in adult HSCs (Wilson et al.,
2010), their interplay to regulate embryonic hematopoiesis
is awaiting for further discovery.
The fine balance between HSC self-renewal and lineage
specification is also stringently regulated by interplays be-
tween genetic and epigenetic modifiers. Among the epige-
netic regulators, microRNAs (miRNAs) are a class of small
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22 nt non-coding RNAs that mainly mediate post-transcrip-
tional control of gene expression via transcript degradation
or by inhibiting protein translation (Bartel, 2004; Gangaraju
and Lin, 2009). Although there is clear evidence supporting
miRNAs as important players for hematopoietic development
and leukemic formation (Garzon and Croce, 2008; Vasilatou
et al., 2010), potential interactions between key transcription
factors and miRNAs in embryonic hematopoiesis are yet to
be understood.
The number of HSCs is very limited in both embryo and in
adult bone marrow (BM) (Morrison et al., 1995). As such, in
vitro differentiation of embryonic stem cells (ESCs) provides
an alternative resource for the study of regulatory events in
hematopoiesis (Keller et al., 1993; Kyba and Daley, 2003;
Xie and Zhang, 2015; Xie et al., 2014). During ESC differ-
entiation, multi-potential FLK1+ hemangioblasts developed
from Brachyury+ mesodermal population (Kennedy et al.,
1997; Kennedy et al., 2007), followed by the formation of
CD41+ primitive HSCs (McKinney-Freeman et al., 2008;
Mikkola et al., 2002) and CD45+ mono-nucleated blood
cells (Hermiston et al., 2003). In this study, we analyzed the
expression of miRNAs during mouse ESC differentiation
through expression arrays, and identified multiple novel
miRNAs highly enriched in CD41+ and CD45+ cells. Fur-
ther analyses demonstrated that these hematopoiesis-related
miRNAs were regulated by a combinational interaction of
key transcriptional factors in blood cells.
RESULTS
The expression of miRNAs during embryonic
hematopoiesis
Previous studies demonstrated that ESCs could differentiate
into three-dimensional structures called embryoid bodies
(EBs) and mimic primitive hematopoietic development in
vitro (Keller et al., 1993; Kyba and Daley, 2003; Wang et al.,
2005). To understand the role of miRNAs in this process,
we utilized the in vitro differentiation system of mouse ESCs
with a GFP transgene driven by the Brachyury (T) promoter.
T-GFP+ (mesodermal population), FLK+ (multi-potential
hemangioblasts), CD41+ (hematopoietic precursors), and
CD45+ cells (mononuclear blood cells) were isolated at vari-
ous time points along EB differentiation (Figure 1A), and mi-
croarray analyses were performed. More than 200 miRNAs
demonstrated differential expression levels in these sorted
populations. Among them, several hematopoiesis-related
miRNAs (including miR-451, miR-142, and miR-146a/b,
etc. (Chen et al., 2004; Fatica et al., 2006; Garzon and
Croce, 2008; Vasilatou et al., 2010)) were highly enriched
in CD41+ and/or CD45+ cells (Figure 1B). By contrast,
miRNAs implicated in maintaining pluripotency, such as
miR-302, miR-293/295, and miR-363, etc. (Gruber et al.,
2014; Houbaviy et al., 2003; Judson et al., 2009; Wang et al.,
2008), were significantly down regulated in those isolated
blood cells from ESCs (Figure 1B). Importantly, we found
increased levels of several miRNAs such as miR-10b and
miR-15a in CD41+ or CD45+ cells (Figure 1B). Roles of
these miRNAs in hematopoiesis are unknown but our data
suggest their potential functions in blood formation.
To confirm these results, we further utilized another ESC
line, Ainv15, and compared the expression of these miRNAs
from sorted CD41+or CD45+cells with CD41– or CD45– pop-
ulations by real-time RT-PCR analyses. Indeed, the miR-
NAs that demonstrated an increased expression in blood cells
compared to T-GFP+ mesodermal precursors were enriched
in the CD41+ or/and CD45+ populations (Figure 1C and D),
whereasmiRNAs that were highly expressed in ESCs showed
decreased levels in CD41+ and/or CD45+ cells compared to
their negative controls (Figure 1C and D), demonstrating a
high quality of the microarray data.
Promoters of miRNAs are bound by multiple key tran-
scription factors in hematopoiesis
We next explored the upstream regulators of these miRNAs
enriched in blood cells with promoter analyses (Figure
2A). Among the transcription factors we examined, GATA3
and SCL were master regulators involved in both primi-
tive and definitive hematopoiesis (Chen and Zhang, 2001;
Gao et al., 2016; Porcher et al., 1996), whereas EKLF
(or KLF1) and PU.1 participated in erythropoiesis and
lymphogenesis respectively (Lohmann and Bieker, 2008;
Nerlov and Graf, 1998). Interestingly, binding motifs of
multiple transcription factors including EKLF and PU.1 that
participated in those different processes of hematopoiesis
were identified at adjacent motifs within the same promoter
regions of miR-144/451, miR-223, and miR-142 (Figure
2A). To confirm these results, Chromatin Immuno Pre-
cipitation (ChIP)-PCR assays were performed in MEL (a
mouse erythroleukemia line) with enforced expression of
FLAG-tagged GATA3, EKLF, and PU.1. Indeed, all three
transcription factors were bound at the predicated regions
in promoters of target miRNAs (Figure 2B). For exam-
ple, although miRNA-144 was believed to play a role in
erythrocyte formation, several binding motifs for GATA3,
EKLF, and PU.1 were found to be co-localized at 400–500
bp upstream of transcription start site (TSS) for miRNA-144
(Figure 2A and B). These results thus suggest that EKLF
and PU.1 may cooperate to fine-tune the transcript level of
miRNA-144 in erythrocytes and myeloid/lymphoid lineages.
Taken together, our data demonstrate a combinational coop-
eration of transcription factors for regulating the expression
of miRNAs involved in hematopoiesis.
Expression of multiple miRNAs is regulated by key tran-
scription factors in hematopoiesis
We next examined whether these key  transcription  factors
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Figure 1   Identify miRNAs that are upregulated during embryonic hematopoiesis. A, A work flow to isolate embryonic blood cells along ESC differentiation.
B, Heatmap of a set of miRNAs that were differentially expressed at distinct stages of blood formation. C and D, Real-time RT-PCR analyses of miRNAs in
sorted CD41– and CD41+ (C) or in CD45– and CD45+ (D) blood cells derived from differentiated ESCs. C and D, Relative expression levels of miRNAs in
CD41+ to CD41– or in CD45+ to CD45– cells are represented as mean±SE of replicates from multiple representative experiments. *, P<0.05; **, P<0.01; ***,
P<0.001.
indeed regulated the expression of their target miRNAs by
a firefly and renilla dual luciferase reporter assay. In this
assay, firefly luciferase driven by promoters of miRNAs was
co-transfected with expressing plasmids encoding renilla
luciferase and FLAG-tagged transcription factors into 293T
cells, and relative firefly (to renilla) luciferase activity was
measured at 24–48 h post transfection. Consistent with the
prediction and ChIP-PCR data above, the master regulator,
GATA3, demonstrated the strongest upregulation of all
miRNAs we tested, whereas EKLF and PU.1 exhibited a
differential modulation of miRNA expression in this assay
(Figure 3A). In addition, GFI1b mainly upregulated the
expression of miR-142 (Figure 3A). By contrast, overexpres-
sion of AML1, a protein involved in both self-renewal of
hematopoietic stem cells and myeloid-lymphoid formation,
decreased the transcript levels of all four miRNAs (Figure
3A), suggesting that a general inhibitory co-factor for AML1
may exist in 293T cells.
We further examined the transcript levels of the miRNA
precursors (pri-miRNAs) by real-time RT-PCRs inMEL cells
upon enforced expression of these transcription factors. In-
deed, GATA3 showed a dramatic upregulation of miR-144
and miR-223, while EKLF mainly increased the expression
of both miR-144/451 and miR-142 (Figure 3B). In addition,
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Figure 2   The promoters of miRNAs were co-bound by multiple transcription factors. A, Predication of binding sites for transcription factors on the promoters
of miRNAs. B, ChIP-PCR analyses with a FLAG antibody against FLAG-tagged transcription factors on genomic DNA extracted fromMEL. TSS, transcription
start site. Negative numbers below panels indicate the upstream distance from TSS of target miRNAs. Relative percentage of input pulled down by the FLAG
antibody to a control IgG was represented as mean±SE of replicates from multiple representative experiments. *, P<0.05; **, P<0.01; ***, P<0.001.
ETS family members including FLI1 and ERG upregu-
lated miR-142 and miR-223, but decreased the level of
miR-144/451 pri-miRNAs (Figure 3B). Notably, the regu-
latory roles of these factors were not exactly the same as
those observed in 293T cells. For example, ectopic AML1
expression displayed an inhibition of all four miRNAs that
we examined in 293T cells, but this suppression was not
observed in MEL (Figure 3B). By contrast, AML upregu-
lated the transcript level of miRNA-223 (Figure 3B). These
result support the importance of setting and specificity of
blood cells (eg. MEL) in which transcriptional regulators are
needed to perform their biological functions.
To further understand the upstream regulators of miR-
NAs during hematopoiesis in vivo, we established multiple
conditional ESC lines in which the expression of key
transcriptional factors was induced upon treatment of doxy-
cycline (Figure 4A–D). In this assay, we found that SCL and
EKLF,  the genes that were reported to be involved in  eryth-
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Figure 3   The expression of miRNAs were regulated by combinational control of multiple transcription factors. A, Luciferase activities driven by upstream
promoter regions of miRNAs were examined upon co-transfection of luciferase reporter plasmids and transgenes to express transcription factors or an empty
vector control. Relative firefly luciferase activity to the Renilla transfection control is represented as mean±SE of replicates from at least three independent
experiments. B, Relative pri-miRNA levels upon enforced expression of various transcription factors in MEL cells were examined by real-time RT-PCR assays.
Data were represented as mean±SE of replicates from at least three independent experiments. *, P<0.05; **, P<0.01; ***, P<0.001.
ropoiesis mainly upregulated miR-144/451 and miR-142,
whereas FLI1 and ERG, the key factors in megakaryocyte
formation (Kruse et al., 2009), significantly increased the
expression of miR-142 and miR-146b (Figure 4A–D), impli-
cating distinct roles of their target miRNAs during primitive
hematopoiesis.
Differential effects of microRNAs on hematopoiesis dur-
ing ESC differentiation
To explore the functions of miRNAs during embryonic
hematopoiesis, we established conditional miRNA ESC
lines, in which the expression of miRNAs was enforced by
doxycycline treatment (Figure 5A). We previously reported
that CD71high population derived from ESCs represents prim-
itive erythroid precursors (Chao et al., 2014), whereas CD45
marked differentiated mononuclear blood cells (Hermiston
et al., 2003), with CD41 as a marker for primitive HSCs
(McKinney-Freeman et al., 2008; Mikkola et al., 2002).
During ESC in vitro differentiation, we found that both
miR-142 and miR-146b transiently increased the formation
of CD71high population (Figure 5B), indicating previously
unknown  functions of these miRNAs  in  primitive  erythro-
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Figure 4   The expression of miRNAs was regulated by various transcription factors during ESC differentiation. A–D, The inducible ESC lines were established
to enforce the expression of various transcription factors in the presence of doxycycline (Dox). The overexpression of targeted transcription factors were
confirmed by RT-PCR analyses (left panels in A–D). Relative expression levels of pri-miRNAs were measured by real-time RT-PCR assays in whole EB
population at various time points during ESC differentiation. – or +dox: upon induction of expression of transcription factors with (+)or without (–) doxycycline
(Dox) treatment. Data are represented as mean±SE of replicates from multiple representative experiments. *, P<0.05; **, P<0.01; ***, P<0.001.
poiesis. In addition, the percentage of CD41+cells was upreg-
ulated upon induction of miR-146b (Figure 5B), suggesting a
role of this miRNA in primitive hematopoiesis. Surprisingly,
there was no obvious alteration in formation of CD71high pop-
ulation upon enforced expression of miR-144/451, a previ-
ously reported miRNA in the erythroid formation (Patrick et
al., 2010). It is possible that sole overexpression of miR-
144/451 was not sufficient to induce primitive erythroid fate
specification during ESC differentiation.
Interestingly, although these miRNAs participate in
hematopoiesis, many of their potential target genes are
the same key transcription factors that regulate miRNA
expression in blood development (Figure 6A). For exam-
ple, bioinformatics prediction indicated that miR-144/451
targeted 3′-UTR of FLI1 and ERG, which in turn appeared
to inhibit the expression of miR-144/451, and thus formed
a negative interactive feedback loop (Figure 6). In addi-
tion, our data suggested GATA3 and SCL activated the
expression of miR-144/451 in HSCs, in turn miR144 might
target GATA3 and SCL (via bioinformatics prediction)
to facilitate erythrocyte fate specification at later stages
of hematopoiesis. Similarly, whereas EKLF upregulated
miR-223 level, miR-223 likely targeted EKLF to negatively
regulate erythrocyte formation in myeloid lineages (Figure
6). Taken together, these data demonstrated that key tran-
scription factors and miRNAs interact with each other to
fine-tune their expression and function during hematopoietic
development.
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Figure 5   (Color online) The differential influence of miRNAs on primitive hematopoiesis during ESC differentiation. A, The conditional ESC lines were
established to enforce the inducible expression of various pr-miRNAs in the presence of doxycycline. The overexpression of targeted pri-miRNAs were con-
firmed by quantitative RT-PCR analyses of whole EB population at various time points during ESC differentiation. B, The percentage of primitive erythroblasts
(CD71high), primitive hematopoietic stem cells (CD41+), and mononuclear blood cells (CD45+) were measured by flow cytometry on whole EB population at
various time points along ESC differentiation. This experiment was conducted multiple times with similar results.
DISCUSSION
Although many miRNAs have been demonstrated to be im-
portant during definitive hematopoiesis and leukemic forma-
tion in adulthood, roles of these miRNAs in embryonic primi-
tive blood development are yet to be understood. In this study,
we identifiedmore than 20miRNAs that were highly enriched
in primitive hematopoiesis from mouse ESCs, including the
ones that had not been previously reported (e.g. miR-10b).
These data thus support the notion that ESC in vitro differen-
tiation system is a powerful platform to identify novel regu-
lators during embryonic development.
To gain knowledge in transcriptional regulation is key to
understand the mechanism that governs complex biological
processes such as hematopoiesis. Previous studies demon-
strated that transcriptional factors at the same stage of adult
hematopoiesis cooperated to regulate their downstream tar-
gets (Wilson et al., 2010). Our bioinformatics prediction and
ChIP-PCR analyses suggest that multiple key transcription
factors from distinct steps of hematopoiesis are also co-lo-
calized at adjacent positions at promoters of their targeted
miRNAs. This observation reveals a combinational coordi-
nation and functional relevance among these transcriptional
regulators. Alternatively, these miRNAs may play multiple
roles at distinct stages of hematopoietic development. In ad-
dition, although reporter assays in 293T cells indicated an
upregulation of luciferase activity driven by the promoter of
miR-142 upon GATA3 overexpression, the level of miR-142
was not changed by increased level of GATA3 in MEL, an
erythroleukemic line (Figure 3). Similarly, SCL enhanced
the expression of miR-223 only in hematopoietic population
(Figure 3), suggesting that additional factors in blood cells
may be needed in coordination with GATA3 or SCL to mod-
ulate the expression of their targeted miRNAs.
It was previously demonstrated that SCL and EKLF pro-
moted erythropoiesis, whereas ETS family members, such
as ERG and FLI1, enhanced megakaryopoietic differentia-
tion by inhibiting erythrocyte formation (Kruse et al., 2009;
Starck et al., 2010). We found that both SCL and EKLF in-
creased the expression of miR-144/451, whereas FLI1 down-
regulated miR-144/451, in turn miR-144/451 might target
FLI1 to inhibit its expression in erythrocytes, thus forming a
negative feedback circuitry to fine-tune the formation of red
blood cells.  Similarly,  miR-223,  a  miRNA  implicated  in
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Figure 6   (Color online) The interacting loop of miRNAs and transcription
factors. A, Predication of target genes regulated by miRNAs. B, The inter-
acting loop of miRNAs and transcription factors identified in this study was
summarized.
myeloid-lymphocyte formation (Fazi et al., 2005), might
target 3′-UTR of EKLF and repress it expression in myeloid
cells. Interestingly, ETS family members, SCL, and EKLF
all enhanced the expression of miR-142, suggesting its role
in both erythropoietic and megakaryopoietic development.
Indeed, we observed that enforced expression of miR-142
or miR-146b transiently increased the formation of CD71high
population from ESCs, indicating previously unknown roles
of these miRNAs in primitive erythropoiesis. Taken together,
our data demonstrated a combinational interplay between




Mouse AML1, ERG, FLI1, GATA1, GATA3, GFI1B, LYL1,
MEIS1, PU.1 and SCL were amplified from a cDNA library
of mouse differentiated ESCs and cloned in fusion with a
1×FLAG tag into plvx-IRES-zsgreen for luciferase reporter
assay, or into pll3.7-IRES-GFP for retroviral infections of
MEL cells. Similarly, ERG, EKLF and FLI1 cDNAs were
cloned into plox for inducible expression of these transcrip-
tion factors. For construction of inducible expression of pri-
miRNAs, about 300 bp upstream and downstream of flank-
ing regions of mature miRNAs were amplified from mouse
genomic DNA and cloned into plox plasmid. Primers for
cloning in this study are listed in Table S1 in Supporting In-
formation.
ESC cell culture and differentiation
Mouse ESCs were cultured on irradiated mouse embryonic
fibroblasts (MEFs) in high glucose Dulbecco’s modified
eagle medium (DMEM) supplemented with 15% fetal bovine
serum (FBS), 2 mmol L–1 L-glutamine, 100 U mL–1 penicillin
and streptomycin (all from Gibco-BRL, USA), 1000 U mL–1
LIF (Millipore, USA), 100 µmol L–1 β-mercaptoethanol, and
1% nonessential amino acids (NEAA) (Gibco-BRL). For
differentiation, ESCs were trypsinized into single cells, col-
lected in EB differentiation medium (IMDM/15% FBS, 200
μg mL–1-saturated transferrin (Calbiochem, Germany), 4.5
mmol L–1 monothiolglycerol and 50 μg mL–1 ascorbic acid
(Sigma, USA), and 2 mmol L–1 L-glutamine, 100 U mL–1
penicillin and streptomycin, all others from Gibco-BRL), and
plated for 45 min to allow MEFs to adhere. Non-adherent
ESCs were collected and plated in hanging drops at 500 cells
per 15 μL drop in an inverted bacterial petri dish. Embryoid
bodies (EBs) were collected at day 2 and transferred into
10 mL EB differentiation medium in slowly rotating 10 cm
petri dishes. Cells were harvested at different time points
by collagenase treatment. To induce gene expression, 0.5–1
μg mL–1 doxycycline was added to the culture medium from
day 2. Stable ESC lines were established by selection of
hygromycine resistant ESCs after electroporation. MEL
cells were cultured in RPMI-1640 medium supplemented
with10% FBS, 100 μg mL–1 streptomycin, and 100 U mL–1
penicillin.
Generation of the doxycycline-inducible ESC lines
The protocol to generate doxycycline inducible ESC lines
was published previously (Kyba et al., 2002; Wang et al.,
2005). In brief, the parental ESC line Ainv15, was electro-
porated with 20 μg plox-ERG, plox-EKLF, or plox-FLI1,
together with 20 μg the Cre recombinase expression plasmid,
pSalk-Cre, followed by selection in ESC culture medium
with 150 μg mL–1 hygromycine (GIBCO). Individual
colonies were picked at day 12 post drug treatment for further
expansion. The ESC line with inducible SCL expression is
a kind gift from Dr. George Daley’s lab at Harvard Medical
School.
Flow cytometry analysis and cell sorting
Dissociated EB cells were incubated with appropriate pri-
mary antibodies for 30 min at 4°C, washed twice, and ana-
lyzed with FACSCalibur (BD Biosciences, USA) for analy-
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ses or sorted with FACSAria II (BD Biosciences). All mon-
oclonal antibodies used in this study were purchased in fluo-
rochrome-coupled forms from BD Pharmingen.
Total RNA preparation, RT-PCR, and quantitative real-
time PCR
Total RNAswere extractedwith Trizol (Invitrogen, USA) and
cDNAs were synthesized using a PrimeScript® RT reagent
Kit (TaKaRa, Japan). Real-time PCR was performed on a
Stratagene MX3000P instrument and analyzed as described
previously (Wang et al., 2013). Primers used in this study are
listed in Table S1 in Supporting Information.
Chromatin immunoprecipitation
Cells were cross-linked with 1% formaldehyde and sonicated
into 200 bp fragments. The cell lysate was precleared before
being immunoprecipitated with a FLAG antibody (Sigma)
or control IgG. Followed by a pull-down with protein A/G
beads (Santa Cruz Biotechnology, USA), a subsequent series
of washes, and elution, enrichment of targeted DNA frag-
ments was finally examined by real-time RT-PCR. Primers
for ChIP-PCR used in this study are listed in Supplementary
Table 1.
Luciferase reporter assay
The upstream DNA fragments of mouse miR-144/451, miR-
223, and miR142 were amplified by PCR and cloned into
pGL4-basic firefly luciferase reporter vector. The reporter
plasmid was then co-transfected into 293T cells with a Re-
nilla-luciferase expressing vector, and plvx-ires-zsgreen plas-
mid containing transgenes of transcription factor driven by a
CMV promoter. The activity of firefly relatively to renilla lu-
ciferase was measured with a luciferase assay kit (Promega,
USA).
Microarray assay
The GFP+ (Brachyury-GFP), Flk1+, CD41+, and CD45+ cells
were sorted at different time points along EB differentiation
by flow cytometer. Gene expression analyses were conducted
with Agilent Whole Mouse Genome (014868) 4×44 multi-
plex format oligo arrays (Agilent technologies, USA) fol-
lowing the Agilent 1-color microarray-based gene expression
analysis protocol. Starting with 500 ng of the total RNA, Cy3
labeled cRNAs was produced according to manufacturer’s
protocol. For each sample, 1.65 μg of Cy3 labeled cRNAs
was fragmented and hybridized for 17 h in a rotating hy-
bridization oven. Slides were washed and scanned with an
Agilent Scanner. Data were obtained using the Agilent Fea-
ture Extraction software (v9.5), using the 1-color default for
all parameters. The Agilent Feature Extraction software was
also used for error modeling, adjusting for additive andmulti-
plicative noises. The final data were processed using Rosetta
Resolver system (v7.2, Rosetta Biosoftware, USA).
Prediction of transcription factor binding sites and
miRNA target genes
Transcription factor binding sites at the promoters of
miRNAs were predicted by the R programming lan-
guage (https://www.bioconductor.org/) and the bind-
ing matrix was obtained from http://www.gene-regula-
tion.com/pub/databases.html and http://jaspar.genereg.net/.
The miRNA target genes and binding motifs were predicted
via http://www.targetscan.org.
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